Stock listing

Viking Therapeutics, Inc.

Selected listing: A12GD6 · LSX · EUR · DE

Viking Therapeutics, Inc. (LS Exchange: A12GD6), Health Technology. Latest release Oct 6, 2026: Viking Therapeutics Announces Initiation of VK2735 Oral…

A12GD6:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: A12GD6
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LS Exchange
Currency: EUR

Latest news from Viking Therapeutics, Inc.

Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity

October 5, 2026

Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity

October 6, 2026

Viking Therapeutics Announces Closing of Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters' Options to Purchase Additional Shares of Common Stock and Convertible Senior Notes

September 28, 2026

Viking Therapeutics Announces Proposed Offerings of Common Stock and Convertible Senior Notes

September 23, 2026

Viking Therapeutics Announces Positive Topline Results from Maintenance Study of GLP-1/GIP Agonist VK2735 Demonstrating the Promise of Multiple Maintenance Dosing Regimens

September 22, 2026

All Viking Therapeutics, Inc. news →

Events

Replays

Viking Therapeutics, Inc. (0VQA) Q2 2026 Earnings Call
Wed, Jul 29, 2026 · 04:30 PM ET
Watch
Viking Therapeutics, Inc. (0VQA) Q1 2026 Earnings Call
Wed, Apr 29, 2026 · 04:30 PM ET
Watch
Viking Therapeutics, Inc. (0VQA) Q4 2025 Earnings Call
Wed, Feb 11, 2026 · 04:30 PM ET
Watch

Research Viking Therapeutics, Inc.

Viking Therapeutics, Inc. company profile

View the public company page for Viking Therapeutics, Inc. on 6ix.

Viking Therapeutics, Inc. news

Read company news and market updates connected to Viking Therapeutics, Inc..

Viking Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Viking Therapeutics, Inc..